Foundation for Innovative New Diagnostics
Budget
€52,201,322
EP Access
0
accredited persons
Staff
2
1 FTE
EU Grants
€2,187,542
Mission & Goals
We are a global non-profit organization driving innovation in the development and delivery of diagnostics to combat major diseases affecting the world’s poorest populations. Diagnostics often do not exist, are inaccessible, or cost too much. They remain under-resourced and overlooked, despite being pivotal for guiding the best treatment for individual patients; for preventing the spread of disease and antimicrobial resistance; and for enhancing surveillance for early disease detection and monitoring. With priorities aligned to those of the global public health community, we turn complex diagnostic challenges into simple solutions through unique partnerships with the public, private and non-profit sectors. Our work bridges R&D to access: we have deep technical and practical experience in the definition of needs, development of fit-for-purpose products...
EU Legislative Interests
EU legislative proposals or policies we will engage with and advocate will relate to global health, international development, research & development, scientific innovation, human rights & gender issues, and the role of the EU and its member states in all of the above, as well as its implications and interactions with low and middle income countries (LMICS). Specifically, policy areas we will be involved with: the EU’s Global Approach on R&I, the new EU strategy with Africa and the EU communication on global health. Specific EU mechanisms and entities we have been and will be interacting with and aiming to engage with and advocate with include the Joint Undertakings Partnerships (such as EDCTP3), Innovative Medicines Initiative, HERA, the EU4HEALTH programme and Horizon Europe.
Communication Activities
Our public relations and communication activities will be related to any of the above-mentioned areas of work/expertise. Specifically, we will engage with areas including international cooperation and external relations with LMICs, global health, research and innovation and gender and human rights.
Interests Represented
Does not represent commercial interests
Member Of
Partnerships are the core of our operating model. Our unique position, bridging the public and private sectors, allows us to bring a diverse set of stakeholders together to resolve technical, financial and logistical barriers to diagnostic innovation in low-resource settings. Our many partners include public, government donors, philanthropic organizations, commercial companies, academic and research institutions, international public health organizations (including non-governmental organizations and foundations), health ministries and disease control programmes. More information, including about our donors, is available here: https://www.finddx.org/partners-donors/ Furthermore, FIND is member of the Global Health Technologies Coalition, Malaria No More, the Swiss Alliance on Neglected Tropical Diseases (SANTD), the Swiss Malaria Group, the G20 Health and Development Partnership, and the Chagas Coalition.
Organisation Members
Our partner and donor organisations are listed here :https://www.finddx.org/partners-donors/ We are also member of the Global Health Technologies Coalition, Malaria No More, the Swiss Alliance on Neglected Tropical Diseases (SANTD), the Swiss Malaria Group, the G20 Health and Development Partnership, and the Chagas Coalition.
Additional Information
Please note that, due to exceptional circumstances, comprising delays to the Swiss Cooperation & Development mandated audit and the non-publication of the Audit report to date, the 2024 Audit exercise is ongoing as it is dependent on the SDC report. We estimate that the 2024 financial report will be issued by our auditors- KPMG for 30 January 2026 as a result of these delays. In the interim, a financial statement of revenue and expenditure has been issued.
Commissioner Meetings
No recorded meetings with EU commissioners.